Seeking Alpha

Cancer Genetics beats by $0.10, beats on revenue

  • Cancer Genetics (CGIX): FQ3 EPS of -$0.61 beats by $0.10.
  • Revenue of $1.7M beats by $0.1M. (PR)
Comments (1)
  • Bought in early Sept at $9.60. Ran up over 100%. Dropped back after Oct 1st and now up again. Up 35% in 2 months. Not too bad. This is a winner.
    13 Nov 2013, 08:24 PM Reply Like
DJIA (DIA) S&P 500 (SPY)